The Exploitation of “Exploitation” in the Tenofovir PrEP Trial in Cameroon: Lessons Learned from Media Coverage of an HIV Prevention Trial

Abstract

Media coverage influences how clinical trials are perceived internationally and in communities where trials occur, affecting recruitment, retention, and political support for research. We conducted a discourse analysis of news coverage from 2004–2005 of a trial in Cameroon on oral PrEP for HIV prevention, to identify messages, communication techniques, and sources of messages that were amplified via media. We identified two parallel discourses: One on ethical concerns about the Cameroon trial, and a second, more general “science exploitation” discourse concerned with the potential for trials with vulnerable participant populations to be conducted unethically, benefiting only wealthy populations. Researchers should overtly address exploitation as an integral, ongoing component of research, particularly where historical or cultural conditions set the stage for controversy to emerge.

Keywords

discourse analysis TDF tenofovir HIV prevention trial communications controversy media analysis research ethics Cameroon Africa

Get full access to this article

View all access options for this article.

References

Abidjan

N. C.

(2005). Cameroon activists want protection of drug test victims. VOA News, February 15.

Act Up-Paris. (2004a). Gilead organise la contamination des travailleuses du sexe. Retrieved June 18, 2009 from http://www.actupparis.org/article1742.html.

Act Up-Paris. (2004b). Tenofovir: Inethical trial. Available ***online at http://www.actupparis.org/article1734.html.

Associated Press. (2004). Cambodian sex workers seek insurance for HIV study-report. Associated Press, March 26. Retrieved June 18, 2009 from http://www.aegis.com/news/ap/2004/AP040353.html.

Bailey

Cruickshank

, & Sharma

(2009). Make your move: Taking clinical trials to the best location. Retrieved June 18, 2009 from http://www.biocientifica.com.ar/docs/Make_Your_Move_S.pdf.

BBC News. (2004). Major HIV drug trial to be halted. Retrieved September 16, 2007 from http://news.bbc.co.uk2/hi/health/3562704.stm.

Beyala

(1995). Lettre d'une Africaine à ses sœurs occidentales. Paris, France: Spengler.

Cameroon Tribune. (2005). Ténofovir: Le promoteur réagit. Cameroon Tribune, February 15.

Cotter

(2001). Discourse and media. In Schiffrin

Tannen

, & Hamilton

H. H.

(Eds.), The Handbook of Discourse Analysis. Malden, MA: Blackwell Publishing.

10.

Department of Health and Human Services, Office of Inspector General. (2001). The Globalization of Clinical Trials: A Growing Challenge in Protecting Human Subjects. OEI-01-00-00190. Washington, DC: Department of Health and Human Services. Available online at oig.hhs.gov/oei/reports/oei-01-00-00190.pdf.

11.

Deutsche Presse-Agentur. (2004). Cambodian prime minister joins push to boycott drug trials. Deutsche Presse-Agentur, August 3. Retrieved June 18, 2009 from http://www.thebody.com/content/art27148.html.

12.

Downing

(2005). As They See It: The Development of the African AIDS Discourse. London, England: Adonis & Abbey Publishers Ltd.

13.

Elias

(2004). Activists demand drug maker Gilead halt AIDS experiments involving prostitutes in Africa, Cambodia. San Jose Mercury News, July 15.

14.

Entman

R. M.

(1991). Framing U.S. coverage of international news: Contrasts in narratives of the KAL and Iran Air incidents. Journal of Communication, 41(4), 6–27.

15.

Entman

R. M.

(1993). Framing: Toward clarification of a fractured paradigm. Journal of Communication, 43(4), 51–58.

16.

Excler

J.-L.

Kochhar

Kapoor

Das

Bahri

Ghosh

M. D.

Ganguly

N. K.

Nayyar

, & Chataway

(2008). Preparedness for AIDS vaccine trials in India. Indian Journal of Medical Research, 127(6), 531–538.

17.

Fairclough

& Wodak

(1997). Critical discourse analysis. In van Dijk

(Ed.), Introduction to Discourse Analysis (pp. 258–284). London, England: Sage.

18.

Fanon

(1967/1991). Black Skin, White Masks. New York, NY: Grove Press.

19.

Forbes

& Mudaliar

(2009). Preventing Prevention Trial Failures: A Case Study and Lessons for Future Trials from the 2004 Tenofovir Trial in Cambodia. Washington, DC: Global Campaign for Microbicides. Available online at www.global-campaign.org/clientfiles/Cambodia.pdf.

20.

Foucault

& Sheridan

(1977). Discipline and Punish: The Birth of the Prison. New York, NY: Pantheon Books.

21.

France 2. (2005). Transcript of France 2 broadcast on the trial, Complément d'enquête. France 2, January 17.

22.

Glickman

S. W.

McHutchison

J. G.

Peterson

E. D.

Cairns

C. B.

Harrington

R. A.

Califf

R. M.

, & Schulman

K. A.

(2009). Ethical and scientific implications of the globalization of clinical research. New England Journal of Medicine, 360(8), 816–823.

23.

Hall

(1980). Encoding/decoding. In Hall

Hobson

Lowe

, & Willis

(Eds.), Culture, Media, Language: Working Papers in Cultural Studies, 1972–79 (pp. 107–116). London, England: Centre for Contemporary Cultural Studies, University of Birmingham.

24.

Hawkins

J. S.

& Emanuel

E. J.

(2008). Introduction: Why exploitation? In Hawkins

J. S.

& Emanuel

E. J.

(Eds.), Exploitation and Developing Countries: The Ethics of Clinical Research (pp. 1–20). Princeton, NJ: Princeton University Press.

25.

Heath

(2006). Best practices in crisis communication: Evolution of practice through research. Journal of Applied Communication Research, 34(3), 245–248.

26.

Hertog

& Fan

(1995). The impact of press coverage on social beliefs: The case of HIV transmission. Communication Research, 22(5), 545.

27.

Huckin

T. N.

(1997). Critical discourse analysis. In Miller

(Ed.), Functional Approaches to Written Text. Washington, DC: USIA. Available online at http://eca.state.gov/education/engteaching/pubs/BR/functionalsec3_6.htm.

28.

IRIN. (2005). Press release: The Cameroonian government must condemn unethical trials, and not people living with HIV/AIDS. IRIN Plus News, January 28.

29.

IRIN Plus News. (2005a). Cameroon: Government suspends trial of AIDS drug. ALLAfrica, February 4.

30.

IRIN Plus News. (2005b). Botswana: Tenofovir trials to start soon—despite controversy. IRIN Plus News, April 19.

31.

Jack

(2005). Mission to save AIDS drug trial from ethical whirlpool: Testing tenofovir on Cameroon prostitutes has landed researchers in a storm of criticism. Financial Times, February 23.

32.

Jones, J. H. & Tuskegee Institute (1993). Bad blood: The Tuskegee syphilis experiment. New and expanded ed., New York, NY: Free Press.

33.

Kang

& Cappella

(2006). Two approaches to emotional reactions toward media messages: Appraisal and message sensation value. Paper presented at the annual meeting of the International Communication Association, Dresden International Congress Centre, Dresden, Germany, June 19–23. Available online at http://www.allacademic.com/meta/p90859_index.html.

34.

Kitzinger

(2000). Media templates: Patterns of association and the (re)construction of meaning over time. Media, Culture & Society, 22(1), 61–84.

35.

Kuypers

J. A.

(2006). Bush's War: Media Bias and Justifications for War in a Terrorist Age. Lanham, MD: Rowman & Littlefield.

36.

Lang

Newhagen

, & Reeves

(1996). Negative video as structure: Emotion, attention, capacity, and memory. Journal of Broadcasting & Electronic Media, 40(4), 460.

37.

Le Messager. (2005). L'Upc et le scandale de Gilead; une commission nationale d'enquête a constituer. Le Messager, February 24.

38.

Len-Rios

& Qiu

(2005). The public's views and what's in the news: A look at clinical trials and second-level agenda setting, Paper presented at the annual meeting of the International Communication Association, Sheraton New York, New York City, NY, May 26–30. Available online at http://www.allacademic.com/meta/p13849_index.html.

39.

MacQueen

McLoughlin

Alleman

Burke

, & Mack

(2008). Partnering for care in HIV prevention trials. Journal of Empirical Research on Human Research Ethics, 3(4), 5–18.

40.

MacQueen

Shapiro

Karim

, & Sugarman

(2004). Ethical challenges in international HIV prevention research. Accountability in Research, 11(1), 49–61.

41.

MacQueen

Namey

Chilongozi

Mtweve

Mlingo

, & Team

(2007). Community perspectives on care options for HIV prevention trial participants. AIDS Care, 19(4), 554–560.

42.

Marx

(1886/1982). Capital: A Critique of Political Economy, Volume 1. New York: International Publishers.

43.

McGrory

Irvin

, & Heise

(2009). Research Rashomon: Lessons from the Cameroon Pre-exposure Prophylaxis Trial Site. Washington, DC: Global Campaign for Microbicides at PATH. Available online at www.global-campaign.org/clientfiles/Cameroon.pdf.

44.

Memmi

(1957). Portrait du colonisé; précédé du portrait du colonisateur. Trans. Greenfield

. Paris, France: Buchet/Chastel.

45.

Miles

(1989). Racism. New York, NY: Routledge.

46.

Mills

Rachlis

Wong

Wilson

, & Singh

(2005). Media reporting of tenofovir trials in Cambodia and Cameroon. BMC International Health and Human Rights, 5(1), 6.

47.

Mohanty

C. T.

Russo

, & Torres

(1991). Third World Women and the Politics of Feminism. Bloomington, IN: Indiana University Press.

48.

Morrison

(1992). Environmental scanning. In Whiteley

(Ed.), The Primer for Institutional Research. Resources in Institutional Research, No. 7. Tallahassee, FL: The Association for Institutional Research.

49.

Nyiama

T. A.

Mack

MacQueen

Guest

, & Guest

E.N.

(2006). Addressing HIV prevention trial challenges through sociobehavioral research: Cameroon's tenofovir trial. Poster presented at the 16th International AIDS Conference, Toronto, Canada, August 13–18.

50.

O'Malley

Kerner

, & Johnson

(1999). Are we getting the message out to all? Health information sources and ethnicity. American Journal of Preventive Medicine, 17(3), 198–202.

51.

Page-Shafer

Saphonn

Sun

Vun

Cooper

, & Kaldor

(2005). HIV prevention research in a resource-limited setting: The experience of planning a trial in Cambodia. The Lancet, 366(9495), 1499–1503.

52.

Pan

& Kosicki

G. M.

(1993). Framing analysis: An approach to news discourse. Political Communication, 10, 55–75.

53.

Parpart

(1995). Deconstructing the Development “Expert”: Gender, Development and the “Vulnerable Groups”. New York, NY: Routledge.

54.

Peterson

Taylor

Roddy

Belai

Phillips

Nanda

Grant

Essie

Clarke

Doh

A. S.

Ridzon

Jaffe

H. S.

, & Cates

(2007). Tenofovir disoproxil fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clinical Trials, 2(5), e27.

55.

Potter

(2004). Discourse analysis. In Hardy

M. A.

& Bryman

(Eds.), Handbook of Data Analysis (pp. 607–624). Thousand Oaks, CA: Sage Publications.

56.

Ramazzotti

S. A.

(2005). Catching AIDS in order to experiment with a vaccine against AIDS. La Stampa, April 15.

57.

Rowland

(2003). Clinical trials seen shifting overseas. International Journal of Health Services, 34(3), 555–556.

58.

Said

(1979). Orientalism. New York, NY: Vintage.

59.

Seme

(2005a). Cameroon: A French conspiracy to evict the American firm Gilead. African Independent, January 29.

60.

Seme

(2005b). Interview with Beth Robinson. African Independent, January 28.

61.

Shah

(2003). Globalization of clinical research by the pharmaceutical industry. International Journal of Health Services, 33(1), 29–36.

62.

Shepherd

(2005). Emergency risk communication. Presentation at Family Health International.

63.

Singh

& Mills

(2005). The abandoned trials of pre-exposure prophylaxis for HIV: What went wrong? PLoS Medicine, 2(9), e234.

64.

Talom

J. M.

(2004). Sida: Le lourd tribut, la duperie des réponses locales. La Novelle Expression, December 1.

65.

Tetchiada

(2005). Santé-Cameroun: De l'argent contre l'éthique dans la lutte contre le SIDA? Inter Press Service, February 9.

66.

The Lancet. (2005). The trials of tenofovir trials. The Lancet, 365(9465), 1111.

67.

Thiers

Sinskey

, & Berndt

(2008). Trends in the globalization of clinical trials. Nature Reviews Drug Discovery, 7, 13–14.

68.

Thompson

(1967). Organizations in Action. New York, NY: McGraw-Hill.

69.

Tome Broadcasting Corp. (2005). Radio broadcast. Cameroon: Tome Broadcasting Corporation.

70.

UNAIDS (2007). Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS).

71.

van Dijk

T. A.

(1988). News as Discourse. Hillsdale, NJ: Erlbaum.

72.

van Dijk

T. A.

(1991). Media contents: The interdisciplinary study of news as discourse. In Jankowski

N. W.

& Jensen

K. B.

(Eds.), A Handbook of Qualitative Methodologies for Mass Communication Research (pp. 108–120). New York, NY: Routledge.

73.

van Dijk

T. A.

(1993). Elite Discourse and Racism. Newbury Park, CA: Sage.

74.

van Dijk

T. A.

(1995). Power and the news media. In Paletz

(Ed.), Political Communication and Action (pp. 9–36). Cresskill, NJ: Hampton Press.

75.

van Dijk

T. A.

(2001). Principles of critical discourse analysis. In Wetherell

Taylor

, & Yates

S. J.

(Eds.), Discourse Theory and Practice: A Reader. Thousand Oaks, CA: Sage Publications.

76.

Wetherell

& Potter

(1992). Mapping the Language of Racism: Discourse and the Legitimation of Exploitation. New York, NY: Columbia University Press.

77.

Wodak

(2004). Critical discourse analysis. In Seale

Gobo

Gubrium

J. F.

, & Silverman

(Eds.), Qualitative Research Practice (pp. 197–212). London; Thousand Oaks, CA: Sage.

78.

Wood

L. A.

& Kroger

R. O.

(2000). Doing Discourse Analysis: Methods for Studying Action in Talk and Text. Thousand Oaks, CA: Sage.